Research
Our lab is dedicated to developing individualized therapies for patients with movement disorders, through both medication-based clinical trials and neuromodulation. We also investigate the brain network dysfunction underlying these diseases, with the goal of using these insights to guide and refine therapeutic strategies.
Cerebellar DBS for Movement Disorders in Children and Young Adults with cerebral palsy
Using advanced brain and movement recordings, we aim to find brain signals linked to dystonic cerebral palsy and understand if this new treatment can improve daily life.
Cerebellar-Cortical Networks in Patients with Dyskinetic Cerebral Palsy
Leveraging cerebellar deep brain stimulation and EEG to reveal neural dynamics underlying motor and non-motor functions and guide next-generation neuromodulation therapies.
LRRK2-targeting therapies for Parkinson’s disease
Evaluating BIIB122's safety, biomarker engagement, and potential to slow disease progression in both idiopathic and genetic forms of Parkinson’s.
When, Where and How to Stimulate the Cerebellum (Adaptive DBS targeting Dentate Nucleus to Treat Ataxia)
Utilizing adaptive deep brain stimulation of the dentate nucleus in SCA6 to define cerebellar biomarkers and develop closed-loop strategies that restore motor function, in collaboration with the University of Florida.